Top Markets
#1 SAFEcoin SAFEcoin +59.28%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +28.62%
#4 Full Moon Full Moon +19.62%
#5 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#6 0G 0G +14.98%
#7 Axelar Axelar +14.88%
#8 Bless Bless +13.79%
#9 VVS Finance VVS Finance +13.70%
#10 Apertum Apertum +12.30%
Coin of the day
SAFEcoin SAFEcoin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Clasificación en acciones #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Precio por acción
$22.26
Última sincronización: 2024-03-22
Capitalización bursátil
$553.40M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Graphite Bio, Inc. (GRPH)

Categoría

Healthcare
Historial de rendimiento por dividendo de Graphite Bio, Inc. (GRPH)
Rendimiento por dividendo (TTM) de Graphite Bio, Inc. (símbolo bursátil: GRPH) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Graphite Bio, Inc. (GRPH) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH